Your browser doesn't support javascript.
loading
Induction and maintenance of bi-functional (IFN-γ + IL-2+ and IL-2+ TNF-α+) T cell responses by DNA prime MVA boosted subtype C prophylactic vaccine tested in a Phase I trial in India.
Munusamy Ponnan, Sivasankaran; Pattabiram, Sathyamurthy; Thiruvengadam, Kannan; Goyal, Rajat; Singla, Nikhil; Mukherjee, Joyeeta; Chatrath, Shweta; Bergin, Philip; T Kopycinski, Jakub; Gilmour, Jill; Kumar, Sriram; Muthu, Malathy; Subramaniam, Sudha; Swaminathan, Soumya; Prasad Tripathy, Srikanth; Luke, Hanna Elizabeth.
Afiliação
  • Munusamy Ponnan S; Department of HIV, National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India.
  • Pattabiram S; Department of HIV, National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India.
  • Thiruvengadam K; Department of HIV, National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India.
  • Goyal R; International AIDS Vaccine Initiative, New Delhi, India.
  • Singla N; International AIDS Vaccine Initiative, New Delhi, India.
  • Mukherjee J; International AIDS Vaccine Initiative, New Delhi, India.
  • Chatrath S; International AIDS Vaccine Initiative, New Delhi, India.
  • Bergin P; IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom.
  • T Kopycinski J; IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom.
  • Gilmour J; IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom.
  • Kumar S; Department of HIV, National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India.
  • Muthu M; Department of HIV, National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India.
  • Subramaniam S; Department of HIV, National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India.
  • Swaminathan S; Department of HIV, National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India.
  • Prasad Tripathy S; Department of HIV, National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India.
  • Luke HE; Department of HIV, National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India.
PLoS One ; 14(3): e0213911, 2019.
Article em En | MEDLINE | ID: mdl-30921340
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / HIV-1 / Vacinas contra a AIDS Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Índia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / HIV-1 / Vacinas contra a AIDS Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Índia